Hanson McClain Advisors »

Vanda Pharmaceuticals shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Vanda Pharmaceuticals (VNDA) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Vanda Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Vanda Pharmaceuticals held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vanda Pharmaceuticals by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.2k 832 4.99
2023-09-30 $423 98 4.33
2023-06-30 $244 37 6.59
2022-09-30 $12k 1.2k 9.72

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)
2023 Etf Series Trust Ii Gmo Us Quality E (QLTY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Usd Inv Grde Etf (USIG)
Nvidia Corporation Call Call Option (Principal) (NVDA)

View all positions for Hanson McClain Advisors

Top funds holding Vanda Pharmaceuticals

BlackRock
Vanguard Group
Renaissance Technologies
Millennium Management
Dimensional Fund Advisors
Tang Capital Management
Acadian Asset Management
Geode Capital Management
State Street Corporation
Krensavage Asset Management
Two Sigma Advisers
Connor, Clark & Lunn Investment Management
Morgan Stanley
Empire Financial Management Company
Federated Investors

View all funds holding Vanda Pharmaceuticals